Perrigo Company PLC

Healthcare · Drug Manufacturers - Specialty & Generic

13.60$ +0.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Perrigo Company PLC (PRGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 4,253 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PRGO
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	845	903	878	739	753	826	826	898	1,024	1,367	1,447	1,822	2,007	2,269	2,755	3,173	3,540	4,061	4,061	4,604	5,281	4,946	4,732	3,870	4,088	4,139	4,452	4,656	4,373	4,253
Cost of Revenue	587	641	671	561	569	614	596	630	764	969	1,046	1,271	1,411	1,523	1,810	2,078	2,260	2,613	2,613	2,892	3,229	2,967	2,900	2,436	2,593	2,723	2,996	2,975	2,831	2,759
Gross Profit	258	261	207	177	184	212	230	268	260	398	402	551	596	746	945	1,096	1,280	1,448	1,448	1,712	2,052	1,980	1,832	1,434	1,495	1,416	1,455	1,680	1,543	1,495
Research & Development	14	16	15	16	18	20	23	28	38	52	66	72	78	83	89	106	115	153	153	188	184	168	219	119	122	122	123	123	112	95
Selling, General & Administrative	–	–	–	123	126	134	148	160	193	275	294	350	232	271	224	240	426	467	411	385	452	461	436	477	479	482	512	522	468	1,056
Total Operating Expenses	185	323	189	146	107	118	145	165	198	278	294	348	334	382	411	518	589	1,047	828	960	1,390	1,273	1,350	1,259	1,230	1,006	1,377	1,529	1,430	1,151
Operating Income	72	-62	18	31	40	87	85	103	-330	111	99	197	247	336	490	569	679	401	567	748	-2,000	598	237	175	265	410	79	152	113	343
Interest Expense	1.2	4.2	14	0.8	3.7	1.4	1.1	0.2	0.2	5.4	16	17	27	29	61	61	104	0.0	176	156	219	173	129	127	128	125	156	174	188	163
Pre-Tax Income	71	-66	4.0	30	44	88	86	106	-331	106	89	180	204	308	451	512	608	273	273	248	-4,848	280	291	148	5.9	259	-139	-8.3	-81	-1,298
Income Tax Expense	26	-14	2.5	11	16	38	32	25	22	35	15	45	63	84	110	119	166	67	67	120	-836	161	160	-11	-38	390	-8.2	-3.9	80	104
Net Income	45	-52	1.5	19	28	50	54	81	-353	71	74	136	144	223	339	402	442	205	205	128	-4,013	120	131	146	-163	-69	-141	-13	-172	-1,425
EBITDA	-32	45	59	49	114	111	131	-294	178	157	289	325	411	594	713	859	939	760	1,210	754	-4,181	1,137	906	662	518	696	356	525	433	-798

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings